This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04655976
Brief Title: Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy (COSTAR Lung)

First Submitted : November 30, 2020
First Submitted that Met QC Criteria : November 30, 2020
First Posted : December 7, 2020

Last Update Submitted that Met QC Criteria : February 18, 2024
Last Update Posted : February 20, 2024